ACOR Price Targets and Analyst Ratings NASDAQ:ACOR
ACOR Forecast. What You Should Know.
ACOR Historical Ratings and Targets
About Acorda Therapeutics
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.